Home > Insider Trading > Filing (0001140361-16-082360)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1572552	Asterias Biotherapeutics Inc.	AST	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532558	Edward Wirth	6300 Dumbarton Circle Fremont CA 94555	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-10-06	2,055	$0.00	3,415	No	4	F	Direct
Common Stock	Disposition	2016-10-06	3,415	$4.12	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	S	Direct

Footnotes

Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,470 Restricted Stock Units, the grant of which was previously reported on a Form 4
Excludes 5,471 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report.
The shares sold were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.05 to $4.15, inclusive. The reporting person undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.